GLP-1 patches would be developed primarily for type 2 diabetes mellitus and obesity management, working through improved glycaemic control, reduced appetite, increased satiety, and delayed gastric emptying, similar to current injectable GLP-1 medications
Access Wegovy (semaglutide) with your insurance, or pay cash and get it delivered directly to you
It is not a reason to dismiss the program, but it is a question that needs an answer before you commit to a 6- or 12-month plan
This medication is intended for patients suffering from obesity and metabolic issues, such as type 2 diabetes
Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptors), which makes it considerably more powerful than semaglutide or even tirzepatide
The current surge in demand began in 2017, when Novo Nordisk released Ozempic to the market